Olivier Jarry

LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.

LiberaBio is a preclinical stage biotech that develops new oncology treatments based on the proprietary MPN technology. This nanotechnology actively targets tumor and metastatic cells and delivers small and large molecules to on-surface or intracellular targets. The company is creating new treatments by delivering novel antibodies targeting intracellular oncoproteins.

Clarety Global Investments ("Clarety") is an investment and finance partnership. Its partners bring decades of financial services, private equity, investment banking, and traditional banking experience to every engagement. We focus on international finance, including trade, mergers and acquisitions, and international private equity funds. In each of these areas, we apply integrated risk management practices and financial structuring that are investor-friendly. Our key regions of experience include Asia, Africa, the EU, and North America. We are not seeking new investment opportunities at this time, except through our own private sources.

Skipta is where your healthcare target is right now 1 network 25 communities 700,000+ verified members You know the type of healthcare professionals you need to reach. We know who they are and how they engage with information. Skipta communities are aligned by specialty or disease state so you get the most relevant message to your target when they’re most ready to engage. Easily launch integrated campaigns that can include featured discussions by verified HCPs about issues that matter to your brand, plus dedicated emails, broadcast banners, custom microsites, conference packages, research, and valuable surveys tailored to your business objectives.

Imagiance LLC is a Limited Liability Company registered in New York State. Business Development & Licensing - Evaluation and due diligence for acquisitions and divestitures in biotech and medtech - Post-Merger Integration (in partnership with MergerWorks) - Funding of biotech and medtech startups (in partnership with Clarety Global Investments) Commercialization and Market Access - Market Access to the US and Europe from firms outside these regions - Market Access for US and European firms to outside these regions - Commercialization and Market Access best practices and organization - Life Cycle Management (LCM) “Beyond The Pill” / Integrated Care - Patient education, coaching and adherence programs (design and implementation) - Healthcare providers and payers integration programs (design and implementation) - Selection of Providers of patient services Digital health 3xBL (TM) Triple Bottom-Line Consulting is a division of Imagiance focused on the “triple-bottom-line": People, Profit, Planet. Our experience includes: - enhancing access to medicines in rural India and in Brazil for major pharmaceutical companies - establishing Public-Private Partnerships (PPP) between private industry, local governments and Non-Governmental Organizations (NGO), in Latin America and in Asia - enhancing access to nutritious baby food in rural Mexico, Brazil, China and South East Asia - expanding distribution of micro-plants for biofuels (ethanol, Straight Vegetable Oil (SVO)) in India and in Brazil for local use by farmer communities - supporting patient counseling and outcome management organizations

Accenture helps the world’s leading enterprises reinvent by building their digital core and unleashing the power of AI to create value at speed for organizations across industries. Our strategy is to be the reinvention partner of choice for our clients and lead in the safe, widespread adoption of AI, and to be the most client-focused, AI-enabled, great place to work in the world. We bring together the talent of our approximately 786,000 people with proprietary assets and platforms, deep process and industry expertise, and leading ecosystem relationships to deliver end-to-end solutions and measurable outcomes at scale. Through our Reinvention Services, we offer broad expertise across Cybersecurity, Digital Core, Finance, Industry and Enterprise, Song, Supply Chain and Engineering, and Talent, with advanced capabilities in AI and Data, Industry and Process, and Technology. We serve approximately 9,000 clients and generated approximately $70 billion in FY25 revenue. Visit us at accenture.com. This LinkedIn company page is moderated. When engaging with Accenture, we encourage everyone to: - Use common courtesy and be respectful of others. - Create your own original content and avoid content that you know to be fraudulent. - Never repost someone elses copyrighted work, unless you have permission. - Never post personal, identifying, or confidential information. We reserve the right to delete comments or posts we deem to be: - Profane, obscene, inappropriate, offensive, abusive material. - Spam, repeated comments and commercial messages and personal advertisements. - Discriminatory or that contain hateful speech of any kind regarding age, gender, race, religion, nationality, sexual orientation, gender identity or disability. - Threats; personal attacks; abusive, defamatory, derogatory, or inflammatory language; or stalking or harassment of any individual, entity or organization. - False, inaccurate, libelous, or otherwise misleading in any way.